BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2005
View Archived Issues
Iptakalim holds promise for pulmonary hypertension treatment
Read More
Profile of novel antipsychotic agent SLV-314, a D2 antagonist/serotonin reuptake inhibitor
Read More
LT-1951 reported safe in patients undergoing CABG surgery
Read More
Studies confirm the antitumor effects of INGN-241 in metastatic melanoma
Read More
New data on the efficacy of aselizumab in psoriasis
Read More
A sunflower oleodistillate shows promise in the treatment of atopic dermatitis
Read More
CombinatoRx and Angiotech sign research and license agreement
Read More
Dainippon and Sumitomo create Dainippon Sumitomo Pharma
Read More
MGI Pharma completes acquisition of Guilford
Read More
Salix and InKine complete merger
Read More
Innogenetics extends collaboration with IDM Pharma
Read More
Elusys to study Anthim for anthrax in phase I study
Read More
Depomed delivers notice of breach to Biovail
Read More
Astellas and MerLion sign drug discovery agreement
Read More
Phase I protocol submitted for Stem Cells Therapeutics' stroke program
Read More
Phase II studies planned for Oxycyte
Read More
N-Butyrylglucosamine shows efficacy in experimental models of arthritis
Read More
Novel agents for diabetes and related complications reported in recent patent literature
Read More
Humira approved for new rheumatoid arthritis indication and psoriatic arthritis
Read More
European approval for shorter course of Peg-Intron and Rebetol
Read More
Long-term effects and safety of ambrisentan in PAH patients
Read More
Approvable letter for Zelapar
Read More
Ispronicline improves cognition in patients with mild impairment
Read More
Innovive to begin phase I trials with INNO-105 for solid malignancies
Read More
Recent Theravance patent discloses novel 5-HT4 receptor agonists for gastrointestinal disorders
Read More
Novel therapeutics for cardiovascular diseases reported
Read More